The top three genes with the highest rates of PANX1 gene alterations were present in melanoma (4.95% of 444 cases), ovarian epithelial tumor (4.28% of 584 cases), and endometrial carcinoma (5.58% of 586 cases) (Figure 1). Here, PANX1 is linked to melanoma.